Please login to the form below

Not currently logged in

Biogen spin-out makes first acquisition

BioverativBioverativ attains rare disease group True North

Germany’s pharma market set for stable growth

german flagAnnual growth of 4.9% expected over next four years

Recordati acquires AstraZeneca blood pressure brands

Italian pharma firm obtains Seloken and Logimax

MSD probed by UK for blocking Remicade biosimilars

Merck and Co - US headquartersPharma giant’s discount scheme for infliximab labelled ‘anti-competitive’

Keytruda is first FDA-approved drug for molecular indication

merck-keytruda-pembrolizumab-melanomaIndicates a significant development in the shift towards personalised medicine

Otsuka refiles 'digital' medicine for mental illness

Proteus ingestible sensorSoluble sensor tracks drug ingestion and shares information with HCPs

Merck says Afferent’s chronic cough drug clears mid-stage trial

Merck & Co HQMK-7264 reduces coughs per hour by 37%

Sanofi/Regeneron's Sarilumab cleared by FDA on second attempt

Sanofi receptionIL-6 inhibitor to treat adult RA patients

content marketingThe new science of content marketing

The role of big data and artificial intelligence in marketing and advertising

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

Founded in 2002, Cactus Communications is a fully integrated, global scholarly communications company with offices in Japan, South Korea, India,...

Latest intelligence

Digital storytelling means building the story around data
The value of digital storytelling in pharma lies in its ability to convert facts and figures into compelling content for patients and HCPs....
Pharma and free medicines: a different perspective
Pfizer have recently announced that they will provide the breast cancer drug, palbociclib, free of charge to patients....
The false economy of following the leader
How can companies in the sector shake things up?...